Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase

Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase

US Patent 12194079 · Granted Jan 14, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stabilized alpha-galactosidase and uses thereof2025
Modified DNase and uses thereof2023
Modified DNase and uses thereof2022
Stabilized alpha-galactosidase and uses thereof2020
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and 2020
Large scale disposable bioreactor2019
Stabilized α-galactosidase and uses thereof2019
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy2018
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and 2018
Nucleic acid construct for expression of alpha-galactosidase in plants and plant2017
Stabilized alpha-galactosidase and uses thereof2017
Inhalable liquid formulations of DNase I2017